These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30595293)

  • 1. Cardiac resynchronization therapy is associated with improvement in clinical outcomes in Indian heart failure patients: Results of a large, long-term observational study.
    Naik A; Singh B; Yadav R; Pandurangi U; Kler TS; Shankar B; Radhakrishnan R; Rajan V; Bhatia V; Kaul U; Varma J; Dora S; Narasimhan C
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S377-S383. PubMed ID: 30595293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy.
    Stabile G; Pepi P; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Rapacciuolo A; Arena G; Marini M; Pieragnoli P; Badolati S; Savarese G; Maglia G; Iuliano A; Botto GL; Malacrida M; Bertaglia E
    Heart Rhythm; 2018 Nov; 15(11):1675-1682. PubMed ID: 29665405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).
    Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC
    Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of CRT on improvement of survival of heart failure patients in real life clinical settings.
    Hudak M; Kerekanic M; Misikova S; Komanova E; Boho A; Stancak B
    Acta Cardiol; 2017 Apr; 72(2):180-187. PubMed ID: 28597793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.
    Goldstein SA; Mentz RJ; Hellkamp AS; Randolph TC; Fonarow GC; Hernandez A; Yancy CW; Al-Khatib SM
    Clin Cardiol; 2019 Feb; 42(2):256-263. PubMed ID: 30548280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):182-8. PubMed ID: 27533993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.
    Lyons KJ; Ezekowitz JA; Liang L; Heidenreich PA; Yancy CW; DeVore AD; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2017 May; 5(5):388-392. PubMed ID: 28449799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF.
    Shukla A; Curtis AB; Mehra MR; Albert NM; Gheorghiade M; Heywood JT; Liu Y; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):433-43. PubMed ID: 23380000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.
    Ziaeian B; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2014 Aug; 64(8):797-807. PubMed ID: 25145524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced left ventricular mechanical dispersion at 6 months follow-up after cardiac resynchronization therapy is associated with superior long-term outcome.
    van der Bijl P; Khidir MJH; Leung M; Yilmaz D; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Heart Rhythm; 2018 Nov; 15(11):1683-1689. PubMed ID: 29753023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Echocardiographic Response to Cardiac Resynchronization Therapy in Initial Nonresponders.
    Burns KV; Gage RM; Curtin AE; Bank AJ
    JACC Heart Fail; 2015 Dec; 3(12):990-7. PubMed ID: 26577619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.